Salih Nafiz Karahan

Salih Nafiz Karahan

Auto-generated profile, based on publicly available information

Salih Nafiz Karahan

Department of Colorectal Surgery, Digestive Disease and Surgery Institute, Cleveland Clinic, Cleveland, Ohio

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2018 in Gastroenterology
Verified
Journal Article
Closed access
PDF file
SHSusan J. Hagen
Susan J. Hagen
LALay-Hong Ang
Lay-Hong Ang
YZYi Zheng
Yi Zheng
SKSalih N. Karahan
Salih N. Karahan
JWJessica Wu
Jessica Wu
JFJames G. Fox
James G. Fox

3 February 2018 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Closed access
PDF file
FCFüsun Can
Füsun Can
SMSirin Menekse
Sirin Menekse
PIPelin Ispir
Pelin Ispir
NANazlı Atac
Nazlı Atac
OAOzgur Albayrak
Ozgur Albayrak
Onder ErgonulOnder Ergonul
Onder Ergonul
We describe the molecular characteristics of colistin resistance and its impact on patient mortality. A prospective cohort study was performed in seven different Turkish hospitals. The genotype of each isolate was determined by MLST and repetitive extragenic palindromic PCR (rep-PCR). Alterations in mgrB were detected by sequencing. Upregulation of pmrCAB, phoQ and pmrK was quantified by RT–PCR. mcr-1 and the genes encoding OXA-48, NDM-1 and KPC were amplified by PCR. A total of 115 patients diagnosed with colistin-resistant K. pneumoniae (ColR-Kp) infection were included. Patients were predominantly males (55%) with a median age of 63 (IQR 46–74) and the 30 day mortality rate was 61%. ST101 was the most common ST and accounted for 68 (59%) of the ColR-Kp. The 30 day mortality rate in patients with these isolates was 72%. In ST101, 94% (64/68) of the isolates had an altered mgrB gene, whereas the alteration occurred in 40% (19/47) of non-ST101 isolates. The OXA-48 and NDM-1 carbapenemases were found in 93 (81%) and 22 (19%) of the total 115 isolates, respectively. In multivariate analysis for the prediction of 30 day mortality, ST101 (OR 3.4, CI 1.46–8.15, P = 0.005) and ICU stay (OR 7.4, CI 2.23–29.61, P = 0.002) were found to be significantly associated covariates. Besides ICU stay, ST101 was found to be a significant independent predictor of patient mortality among those infected with ColR-Kp. A significant association was detected between ST101 and OXA-48. ST101 may become a global threat in the dissemination of colistin resistance and the increased morbidity and mortality of K. pneumoniae infection.

29 August 2025 in Diseases of the Colon & Rectum
Verified
Journal Article
Closed access
SKSalih N. Karahan
Salih N. Karahan
MOMustafa Oruc
Mustafa Oruc
KEKamil Erozkan
Kamil Erozkan
MVMichael A. Valente
Michael A. Valente
ABAnuradha R. Bhama
Anuradha R. Bhama
EGEmre Gorgun
Emre Gorgun
BACKGROUND: Total neoadjuvant therapy is increasingly used for locally advanced rectal cancer. However, the optimal interval between total neoadjuvant therapy and surgery remains unclear. Existing trials report intervals ranging from 2–4 weeks to 11–18 weeks, and many surgeons believe that surgery becomes more difficult after a certain point, but the exact timing and its impact on complications are unknown. OBJECTIVE: To identify the time point after total neoadjuvant therapy when surgery becomes more challenging and define an optimal window for minimizing postoperative complications in patients proceeding directly to resection. DESIGN: Retrospective cohort study. SETTINGS: Single tertiary care center. PATIENTS: Patients with locally advanced rectal cancer who completed total neoadjuvant therapy between 2015 and 2023 and underwent surgery due to primary disease or regrowth during a watch-and-wait strategy were included. INTERVENTION: Total neoadjuvant therapy followed by surgery. MAIN OUTCOME MEASURES: The primary outcome was the association of time from total neoadjuvant therapy completion to surgery with postoperative complication rates. Secondary outcomes included perioperative and postoperative outcomes. RESULTS: Among 212 patients (median age 57 [interquartile range 50–66] years; 59% men), 42% experienced complications (15% Clavien-Dindo grade 3 or higher). Restricted cubic spline analysis suggested a dip in overall morbidity around 7 to 12 weeks, with an increased risk beyond 24 weeks. Patients who underwent operations after ≥24 weeks (n = 29) had higher rates of margin positivity (17% vs 3%, p < 0.01), reoperations (21% vs 8%, p = 0.04), and severe complications (28% vs 13%, p = 0.03) compared to those who underwent operations earlier (n = 183). LIMITATIONS: Single-center retrospective design, univariate spline analysis, and a relatively small subset of patients beyond 24 weeks limit generalizability. CONCLUSIONS: Surgical timing after total neoadjuvant therapy is associated with perioperative outcomes. Delaying surgery beyond 24 weeks is linked to greater surgical difficulty and morbidity. Additional multicenter studies are needed to confirm these findings and refine timing recommendations. See Video Abstract . MOMENTO ÓPTIMO PARA LA CIRUGÍA DEL CÁNCER RECTAL TRAS UNA TERAPIA NEOADYUVANTE TOTAL: ¿CUÁNDO SE VUELVE REALMENTE DIFÍCIL LA CIRUGÍA?: ANTECEDENTES: La terapia neoadyuvante total se utiliza cada vez más para el cáncer rectal localmente avanzado. Sin embargo, aún no está claro cuál es el intervalo óptimo entre la terapia neoadyuvante total y la cirugía. Los ensayos existentes informan de intervalos que oscilan entre 2-4 semanas y 11-18 semanas, y muchos cirujanos creen que la cirugía se vuelve más difícil después de cierto punto, pero se desconoce el momento exacto y su impacto en las complicaciones. OBJETIVO: Identificar el momento después de la terapia neoadyuvante total en el que la cirugía se vuelve más difícil y definir un intervalo óptimo para minimizar las complicaciones posoperatorias en los pacientes que pasan directamente a la resección. DISEÑO: Estudio de cohorte retrospectivo. ENTORNO: Centro terciario único. PACIENTES: Pacientes con cáncer rectal localmente avanzado que completaron la terapia neoadyuvante total entre 2015 y 2023 y se sometieron a cirugía debido a la enfermedad primaria o al recidiva durante una estrategia de espera vigilada. INTERVENCIÓN: Terapia neoadyuvante total seguida de cirugía. PRINCIPALES MEDIDAS DE RESULTADO: El resultado principal fue la asociación entre el tiempo transcurrido desde la finalización de la terapia neoadyuvante total hasta la cirugía y las tasas de complicaciones posoperatorias. Los resultados secundarios incluyeron resultados perioperatorios y posoperatorios. RESULTADOS: Entre los 212 pacientes (mediana de edad 57 [IQR 50-66], 59 % hombres), el 42 % experimentó complicaciones (15 % Clavien-Dindo ≥3). El análisis de splines cúbicos restringidos sugirió una disminución de la morbilidad general alrededor de las 7-12 semanas, con un aumento del riesgo más allá de las 24 semanas. Los pacientes operados ≥24 semanas (n = 29) presentaron tasas más altas de positividad de los márgenes (17 % frente a 3 %, p < 0,01), reintervenciones (21 % frente a 8 %, p = 0,04) y complicaciones graves (28 % frente a 13 %, p = 0,03) en comparación con los operados antes (n = 183). LIMITACIONES: El diseño retrospectivo de un solo centro, el análisis spline univariante y un subconjunto relativamente pequeño más allá de las 24 semanas limitan la generalización. CONCLUSIÓN: El momento de la cirugía después de la terapia neoadyuvante total se asocia con los resultados perioperatorios. Retrasar la cirugía más allá de las 24 semanas se relaciona con una mayor dificultad quirúrgica y morbilidad. Se necesitan más estudios multicéntricos para confirmar estos hallazgos y refinar las recomendaciones sobre el momento adecuado. ( AI-generated translation )

1 September 2023 in Turkish Journal of Surgery
Verified
Journal Article
Open access
PDF file
IOIbrahim Halil Ozata
Ibrahim Halil Ozata
SSSerkan Sucu
Serkan Sucu
SKSalih N. Karahan
Salih N. Karahan
BKBilge Kaan Kılıçoğlu
Bilge Kaan Kılıçoğlu
MKMekselina Kalender
Mekselina Kalender
EBEmre BALIK
Emre BALIK
Objective: Laparoscopic totally extraperitoneal inguinal hernia repair (TEP) surgery technique includes three key steps: reaching the preperitoneal space, reducing hernias, and placement of mesh. However, reaching the preperitoneal space can be complicated in patients with previous lower abdominal surgeries. This study aimed to assess the feasibility of laparoscopic inguinal TEP in patients with previous prostatectomies. Material and Methods: Inguinal hernia patients who underwent laparoscopic TEP between January 2015 and February 2021 at Koç University Faculty of Medicine, Department of General Surgery, were included in this retrospective study. The operations were performed by five senior surgeons experienced in laparoscopy. Patients were divided into two study groups, as the radical prostatectomy (RP) group which included patients with previous prostatectomy non-RP which included patients without previous radical prostatectomy. Operative time (OT), length of hospital stay (LOS), and postoperative complications were compared within two groups. Results: Three hundred and forty-nine patients underwent laparoscopic TEP, and 27 had previous prostatectomies. Among them, 190 patients had unilateral inguinal hernias, and 159 had bilateral inguinal hernias. Mean age of the patients in the non-RP and RP groups was 58.1 ± 14.7 and 73.9 ± 9.6 years, respectively. Only one (3.7%) case was complicated with urinary tract infection in the RP group, and 10 (3.1%) were complicated in the non-RP group. Complications for the non-RP group include hematomas in six cases, urinary tract infection in three cases, and urinary retention in one case. No significant difference in mean operative time was seen between non-RP and RP groups (p= 0.43). There was no significant difference in the means of the length of hospital stay between the two groups (p= 0.7). Conclusion: Laparoscopic TEP in patients with a previous prostatectomy can be performed safely without prolonging the operative time and increasing the length of hospital stay.

26 June 2018 in Clinical Kidney Journal
Verified
Journal Article
Open access
PDF file
SKSalih Karahan
Salih Karahan
BABaris Afsar
Baris Afsar
MKMehmet Kanbay
Mehmet Kanbay
Asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, is related with impaired endothelial function and poor outcomes in chronic kidney disease (CKD) patients. In addition, oxidative stress and inflammation are also a common problem in CKD patients, and both have an important role in the development and progression of atherosclerosis and increased cardiovascular events in CKD. Ascorbic acid might be a promising agent in CKD for improving outcome by decreasing oxidative stress and ADMA levels.

30 April 2020 in Current Surgery Reports
Verified
Journal Article
Closed access
PDF file
EKEmin Kose
Emin Kose
SKSalih Nafiz Karahan
Salih Nafiz Karahan
EBEren Berber
Eren Berber